Bilimsel çalışmalar

Doç. Dr. Eda Tanrıkulu Şimşek

30 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Simsek ET, Coban E, Atag E, Gungor S, Sari M, Gurleyik G. The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer. J Coll Physicians Surg Pak. 2021 Jul;30(7):792-797.

    Kaynak: anadolusaglik.org profil sayfası

  2. Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. J Clin Pathol. 2016 Sep;69(9):810-6.

    Kaynak: anadolusaglik.org profil sayfası

  3. Tanrikulu Simsek E, Dane F. Nutrition in Cancer Patients Who Have Problems in Oral Taking. Türkiye Klinikleri Tıbbi Onkoloji Kanser ve Beslenme Özel sayısı. Turkiye Klinikleri J Med Oncol-Special Topics. 2016;9(3):58-64.

    Kaynak: anadolusaglik.org profil sayfası

  4. Tanrikulu Simsek E, Dane F. Primary Central Nervous System Lymphomas: Diagnosis, Staging and Systemic Treatment. Erişkin Santral Sinir Sistemi Tümörleri Özel sayısı. Turkiye Klinikleri J Med Oncol-Special Topics. 2019. p.78-83.

    Kaynak: anadolusaglik.org profil sayfası

  5. Tanrıkulu Şimşek E, Beşiroglu M, Aktaş B, Koca S, Halil S, Alan Ö, Hasanov R, Akgül Babacan N, Öztürk MA, Kaya S, Ozdogan OC, Dane F, Yumuk PF. Can we Restart Vemurafenib after Severe Hepatotoxicity? A Case Report. J J Gastro Hepato. 2015, 2(4): 025.

    Kaynak: anadolusaglik.org profil sayfası

  6. Simsek ET, Coban E, Atag E, Gungor S, Aker F, Sari M. The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients Planning Neoadjuvant Treatment. J Coll Physicians Surg Pak. 2021

    Kaynak: anadolusaglik.org profil sayfası

  7. Tanrıkulu Şimşek E, Bayram B, Yıldırım A, Eşkazan AE. Is it possible to predict the pCR with CBC? A commentary on "correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer" by Meng et al. Transl Oncol. 2022 Jun;20:101403. doi: 10.1016/j.tranon.2022.101403. Epub 2022 Mar 23.

    Kaynak: anadolusaglik.org profil sayfası

  8. Alan O, Akin Telli T, Ercelep O, Tanrikulu Simsek E, Basoglu Tuylu T, Mutis A, Hasanov R, Kaya S, Akgül Babacan N, Dane F, Yumuk PF. Chordoma: a case series and review of the literature. J Med Case Rep. 2018 Aug 27;12(1):239.

    Kaynak: anadolusaglik.org profil sayfası

  9. Alan O, Telli TA, Ercelep O, Hasanov R, Simsek ET, Mutis A, Ones T, Kaya H, Yumuk PF. A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy. Curr Probl Cancer. 2019 Aug;43(4):308-311

    Kaynak: anadolusaglik.org profil sayfası

  10. Kaya S, Aktas B, Tanrikulu Simşek E, Akif Ozturk M, Dede F, Kaya H, Ugurlu U, Ozgen Z, Koca S, Halil S, Hasanov R, Alan O, Akgul Babacan N, Ercelep O, Dane F, Gumus M, Yumuk F. Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer. J BUON. 2017 Sep-Oct;22(5):1191-1198.

    Kaynak: anadolusaglik.org profil sayfası

  11. Gurleyik G, Aksu SA, Aker F, Tekyol KK, Tanrikulu E, Gurleyik E. Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy. Ann Surg Treat Res. 2021 Jun;100(6):305-312.

    Kaynak: anadolusaglik.org profil sayfası

  12. Kaytaz Tekyol K, Gurleyik G, Aktaş A, Aker F, Tanrikulu E, Tekyol D. Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes. Cureus. 2021 Apr 30;13(4):e14774. doi: 10.7759/cureus.14774. PMID: 34094739; PMCID: PMC8164848.

    Kaynak: anadolusaglik.org profil sayfası

  13. Demirelli B, Babacan NA, Ercelep Ö, Öztürk MA, Kaya S, Tanrıkulu E, Khalil S, Hasanov R, Alan Ö, Telli TA, Koca S, Arıbal ME, Kuzan B, Dane F, Yumuk PF. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Nutr Cancer. 2021;73(2):230-238.

    Kaynak: anadolusaglik.org profil sayfası

  14. Demircan NC, Dane F, Ozturk MA, Babacan NA, Besiroglu M, Kaya S, Ercelep O, Tanrikulu E, Halil S, Koca S, Alan O, Hasanov R, Yumuk PF. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy. J BUON. 2019 Jul-Aug;24(4):1494-1500.

    Kaynak: anadolusaglik.org profil sayfası

  15. Dulundu E, Attaallah W, Tilki M, Yegen C, Coskun S, Coskun M, Erdim A, Tanrikulu E, Yardimci S, Gunal O. Simultaneous resection for colorectal cancer with synchronous liver metastases is a safe procedure: Outcomes at a single center in Turkey. Biosci Trends. 2017 May 23;11(2):235-242.

    Kaynak: anadolusaglik.org profil sayfası

  16. Aydin D, Sendur MA, Kefeli U, Umut Unal O, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Bala Ustaalioglu B, Sener Dede D, Esbag O, Inal A, Bilir C, Bilici A, Harputlu H, Berk V, Sevinc A, Yildirim Ozdemir N, Yildirim E, Sonkaya A, Ali Ustaoglu M, Gumus M. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO). J BUON. 2016 Sept-Oct;21(5):1242-1249.

    Kaynak: anadolusaglik.org profil sayfası

  17. Demirci NS, Aksoy S, Özdemir NY, Erdem GU, Ozcelik M, Tanrikulu E, Eren T, Bozkaya Y, Sahin S, Başol F, Aslan SA, Zengin N, Güllü İ. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study. Curr Med Res Opin. 2017 Mar;33(3):401-407.

    Kaynak: anadolusaglik.org profil sayfası

  18. Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clin Colorectal Cancer. 2017 Sep;16(3):220-227.

    Kaynak: anadolusaglik.org profil sayfası

  19. Arı MC, Büyüktaş D, Eşkazan AE, Ongören Aydın S, Tanrıkulu E, Başlar Z, Buyru AN, Ferhanoğlu B, Aydın Y, Tüzüner N, Soysal T. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2012 Sep;29(3):242-7.

    Kaynak: anadolusaglik.org profil sayfası

  20. Ugurlu S, Caglar E, Yesim TE, Tanrikulu E, Can G, Kadioglu P. Evaluation of thyroid nodules in Turkish population. Intern Med. 2008;47(4):205-9.

    Kaynak: anadolusaglik.org profil sayfası

  21. Ercelep O, Alan O, Telli TA, Tuylu TB, Arıkan R, Demircan NC, Simsek ET, Babacan NA, Kaya S, Dane F, Bozkurtlar E, Ones T, Lacin T, Yumuk PF. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori. 2021 Jun;107(3):231-237.

    Kaynak: anadolusaglik.org profil sayfası

  22. Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC, Simsek E, Hamuryudan V, Kucukoglu S, Yazici H. The estimated pulmonary artery pressure can be elevated in Behçet's syndrome. Respir Med. 2011 Nov;105(11):1739-47.

    Kaynak: anadolusaglik.org profil sayfası

  23. Ercelep Ö, Akın Telli T, Alan Ö, Hasanov R, Tanrıkulu Şimşek E, Akgül Babacan N, Kaya S, Kaya H, Dane F, Yumuk PF. Smokers having activating egfr mutant non-small cell lung cancer might Benefit from EGFR-TKI Treatment – Single-Center Experience. Turk J Oncol 2020;35(3):334–9.

    Kaynak: anadolusaglik.org profil sayfası

  24. Bavunoğlu I, Balta M, Tanrıkulu E, Türkmen Z, İkizceli İ. Unexpected Diagnosis in the Metropolis: Organophosphate Poisoning. JAEMCR 2012; 3(2): 52-5.

    Kaynak: anadolusaglik.org profil sayfası

  25. Oven B, Celik S, Okten IN, Tanrıkulu E, Aliyev A, Seker M. Approachment to the Brain Metastasis without Extracranial Metastasis of the HER2 Positive Metastatic Breast Cancer. Volume 3(6): 2-6. 2020.

    Kaynak: anadolusaglik.org profil sayfası

  26. Alan Ö, Ercelep Ö, Akın Telli T, Tanrıkulu Şimşek E, Hasanov R, Başoğlu T, Öztürk MA, Kaya S, Akgül Babacan Nİ Laçin T, Bozkurtlar E, Dane F, Yumuk PF. Opere Erken Evre Akciğer Kanseri Hastalarında Prognostik Faktörler Retrospektif Tek Merkez Sonuçları. Namık Kemal Tıp Dergisi 2020; 8(3): 376 - 382.

    Kaynak: anadolusaglik.org profil sayfası

  27. Gungor S, Gunaydin UM, Yakar HI, Simsek ET, Akbiyik AG, Keskin H. Total Lesion Glycolysis Obtained by FDG PET/CT in Diagnosing Solitary Pulmonary Nodules. J Coll Physicians Surg Pak. 2023 Jan;33(1):27-31. doi: 10.29271/jcpsp.2023.01.27.PMID: 36597231

    Kaynak: anadolusaglik.org profil sayfası

  28. Sari M, Atag E, Demir T, Simsek ET, Coban E, Cikrikcioglu M. Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients. J Coll Physicians Surg Pak. 2022 Feb;32(2):186-192. doi: 10.29271/jcpsp.2022.02.186.PMID: 35108789

    Kaynak: anadolusaglik.org profil sayfası

  29. Caliskan Yildirim E, Atag E, Coban E, Umit Unal O, Celebi A, Keser M, Uzun M, Keskinkilic M, Tanrikulu Simsek E, Sari M, Yavuzsen T. The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study. Breast. 2023 Aug;70:56-62. doi: 10.1016/j.breast.2023.06.006. Epub 2023 Jun 14.

    Kaynak: anadolusaglik.org profil sayfası

  30. Aker FV, Ekren E, Dogan M, Gurleyik G, Tanrikulu E, Oven BB. Clinicopathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma-NOS: Worse or Better? J Coll Physicians Surg Pak. 2022 Sep;32(9):1196-1201. doi: 10.29271/jcpsp.2022.09.1196.PMID: 36089720

    Kaynak: anadolusaglik.org profil sayfası